CBN isolate

When there is so much potential with minor cannabinoids, is it any wonder that Sanobiotec wants to continue researching and developing them as much as possible?
We work with a variety of minor cannabinoids, because we know that there is still so much more to learn about them. CBC, CBDV and other minor cannabinoids, could have just as much (if not more) benefits for people in a therapeutic sense. We just have to get to know them a little better.
On that note, allow us to introduce you to another minor cannabinoid, cannabinol (CBN).

Cannabinol is another example of a minor cannabinoid with plenty of unlocked potential.
A non-intoxicating compound, research into CBN cannabinoid has only scratched the surface in terms of how effective it could prove to be for a number of different applications and purposes.
Recent research into this minor cannabinoid, CBN, has focused on determining just how effective it could prove to be in the following areas:

As an antibacterial – CBN may prove to have seriously powerful antibacterial effects, and research is ongoing into how both CBN isolate and CBN distillate may be used for this purpose.
For pain relief – when looking to use cannabinol isolate for pain relief, the ease of use is very important for the end consumer, which is why research into how it can be taken as a CBN drug is crucial, looking at options such as CBN powder. It’s also worth pointing out that CBN can start to kick in within 30 to 40 minutes, meaning that its application as a pain relief could have huge benefits for the end-user.
As a sleep aid – CBN has been shown to be effective as a sleep aid, helping consumers to get some much-needed shut-eye. The secondary benefits of this are huge, as a good night’s sleep can sometimes be the best medicine.

A summary of recent research areas where this cannabinoid has been involved:

• Amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease)
• Alzheimer’s disease
• Attention deficit hyperactivity disorder (ADHD)
• Dental Health
• Loss of appetite
• Neuroprotection
• Seizure

When consumers are looking to buy CBN isolate, and they see advertisements for CBN for sale or CBN isolate for sale, the content of the CBN should always be of top quality if the maximum benefits are going to be achieved.
It can be confusing, but Sanobiotec is looking to lift the mystery from minor cannabinoids and help bring them into the mainstream along with the major cannabinoids CBG and CBD.
At Sanobiotec, we’re only interested in maximising the benefits that people will find from using these minor cannabinoids.
It’s all about getting major benefits from minor cannabinoids, and we know exactly how to do just that.
Our team is committed to understanding these compounds as well as we possibly can, so that we can enable people to get the most out of their use.
Unlocked potential just needs the right set of keys, and Sanobiotec has the right set of keys for the job.

This is a summary of the research interests for each cannabinoid being discussed. These statements have not been evaluated by regulatory bodies such as Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure or prevent any disease. Sanobiotec has provided this summary solely to provide the reader with information on the types of studies being conducted on cannabinoids.

Sources:

1. Aiken C et al. A cell‐based screen for drugs to treat Huntington’s disease. Neurobiology of Disease, 16(3), 546–555 (2004).

2. Appendino G et al. Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod 2008 Aug; 71 (8): 1427-30.

3. Dawidowicz A L et al. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action. Fitoterapia 2021 Jul; 152:104915.

4. De Petrocellis L et al. Effects of cannabinioids and cannabinoid enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Brit J Pharmacol 2011 Aug; 163 (7):1479.

5. Farrimond JA et al. Cannabinol and cannabidiol exert opposing effects on rate feeding patterns. Psychopharmacology 2012; 223: 117.

6. Hergenrather J et al. Cannabinoid and terpenoid doses are associated with adult ADHD status of medical cannabis patients. Rambam Maimondies Medical Journal 2020; 11(1) online.

7. Marsicano G et al. Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1. Journal of Neurochemistry, 80(3), 448–456 (2002).

8. Schubert D et al. Efficacy of cannabinoids in a pre-clinical platform for Alzheimer’s disease. Molecular Neurobiology 2019; 56: 7719.

9. Stahl V et al. Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation. Cureus 12(1): e6809, January 2020.

10. Thornton C et al. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish. Epilepsy Behav, 2020 Sept; 110:107152.

11. Weydt P et al.Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotrophic Lateral Sclerosis 2005 Sep, 6(3): 182-184).

12. Wong H and Cairns BE. Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Arch Oral Biol 2019 Aug; 104: 33-39.

13. Zhong, N. et al. Cannabinol inhibits proliferation and induces cell cycle arrest and apoptosis in glioblastoma, hepatocellular carcinoma and breast cancer cells. University of Lethbridge Msc Thesis (2020).

14. https://www.medicalnewstoday.com/articles/cbd-vs-cbn